Mias, Céline <br/><br/>
Mesenchymal stem cells promote matrix metalloproteinase secretion by cardiac fibroblasts and reduce cardiac ventricular fibrosis after myocardial infarction.  [electronic resource] 

 -  Stem cells (Dayton, Ohio)  Nov 2009 
 - 2734-43 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1549-4918 
<br/><br/><label>Standard No.: </label>10.1002/stem.169  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Actins--metabolism<br/>Animals<br/>Blotting, Western<br/>Cell Survival--drug effects<br/>Cells, Cultured<br/>Collagen--metabolism<br/>Collagenases--metabolism<br/>Culture Media, Conditioned--pharmacology<br/>Echocardiography<br/>Fibroblasts--drug effects<br/>Fibrosis--prevention & control<br/>Heart Ventricles--drug effects<br/>Immunohistochemistry<br/>Matrix Metalloproteinase 1--genetics<br/>Matrix Metalloproteinase 2--genetics<br/>Matrix Metalloproteinase 9--genetics<br/>Mesenchymal Stem Cell Transplantation<br/>Mesenchymal Stem Cells--cytology<br/>Mice<br/>Mice, Knockout<br/>Myocardial Infarction--metabolism<br/>Polymerase Chain Reaction<br/>Quantum Dots<br/>Rats<br/>Tissue Inhibitor of Metalloproteinase-2--metabolism